河北医学2024,Vol.30Issue(5) :798-805.DOI:10.3969/j.issn.1006-6233.2024.05.017

肝癌组织中miR-1470 PATZ1表达水平与患者5年内预后的关系

Association between microRNA-1470 and PATZ1 Expression in Hepatocellular Carcinoma Tissues and Patient Prognosis within 5 Years

田利晖 张振翼 袁增江 张欣 赵孟雷 霍浩然 王军委
河北医学2024,Vol.30Issue(5) :798-805.DOI:10.3969/j.issn.1006-6233.2024.05.017

肝癌组织中miR-1470 PATZ1表达水平与患者5年内预后的关系

Association between microRNA-1470 and PATZ1 Expression in Hepatocellular Carcinoma Tissues and Patient Prognosis within 5 Years

田利晖 1张振翼 1袁增江 1张欣 1赵孟雷 1霍浩然 1王军委1
扫码查看

作者信息

  • 1. 河北省邯郸市中心医院普外科,河北 邯郸 056000
  • 折叠

摘要

目的:探讨肝癌组织中微小RNA-1470(miR-1470)、POZ结构域和 AT 结合基序锌指蛋白1(PATZ1)表达水平与患者5 年内预后的关系.方法:选取2015 年9 月至2018 年8 月在邯郸市中心医院接受根治术治疗的肝癌患者 135 例,术中留取肝癌组织及相应癌旁正常组织(距肿瘤边缘 2cm 以上的正常肝脏组织).采用免疫组织化学法检测PATZ1 蛋白表达;采用实时荧光定量 PCR 法检测 miR-1470、PATZ1 mRNA表达;术后进行5 年的随访,统计 5 年总生存率.比较肝癌组织和癌旁正常组织中miR-1470、PATZ1 mRNA和蛋白表达情况;分析肝癌组织中miR-1470、PATZ1 mRNA表达与临床病理参数的关系,二者表达的相关性及与预后的关系,影响预后的危险因素;双荧光素酶报告基因实验验证miR-1470 与PATZ1 的靶向关系.结果:肝癌组织PATZ1 蛋白阳性表达率明显低于癌旁正常组织(P<0.05).与癌旁正常组织比较,肝癌组织中miR-1470 表达水平明显升高,PATZ1 mRNA表达水平明显降低(P<0.05).肝癌组织中 miR-1470、PATZ1 mRNA 低表达、高表达患者在血清甲胎蛋白(AFP)水平、中国肝癌分期方案(CNLC)分期及有无脉管癌栓方面,差异均有统计学意义(P<0.05).肝癌组织中miR-1470 与PATZ1 mRNA表达呈负相关(P<0.05).miR-1470 低表达患者、PATZ1 mRNA 高表达患者5 年总生存率分别明显高于miR-1470 高表达患者、PATZ1 mRNA 低表达患者(P<0.05).CNLC 分期Ⅲ期、脉管癌栓、miR-1470 高表达及PATZ1 mRNA低表达是影响肝癌患者预后不良的独立危险因素(P<0.05).miR-1470 可负向调控PATZ1 表达.结论:肝癌组织中miR-1470 表达上调,PATZ1 表达下调,两者呈负相关,均可作为评估肝癌患者预后的生物标记物,且miR-1470 可负向调控PATZ1 表达.

Abstract

Objective:To investigate the association between the expression levels of microRNA-1470(miR-1470),POZ domain and AT-binding motif zinc finger protein 1(PATZ1)in hepatocellular carcinoma(HCC)tissues and patient prognosis within 5 years.Methods:A total of 135 patients with HCC who under-went radical resection at Handan Central Hospital from September 2015 to August 2018 were enrolled in this study.HCC tissues and corresponding adjacent normal tissues(normal liver tissues more than 2 cm away from the tumor margin)were collected during surgery.Immunohistochemistry was used to detect PATZ1 protein ex-pression;real-time fluorescence quantitative PCR was used to detect miR-1470 and PATZ1 mRNA expres-sion.Patients were followed up for 5 years,and 5-year overall survival rates were calculated.The expression of miR-1470 and PATZ1 mRNA and protein in HCC tissues and adjacent normal tissues was compared;the relationship between miR-1470 and PATZ1 mRNA expression and clinicopathological parameters,their corre-lation,and their association with prognosis were analyzed;and the risk factors affecting prognosis were identi-fied.Dual luciferase reporter gene assay was used to verify the target relationship between miR-1470 and PATZ1.Results:The positive expression rate of PATZ1 protein in HCC tissues was significantly lower than that in adjacent normal tissues(P<0.05).Compared with adjacent normal tissues,the expression level of miR-1470 was significantly upregulated and the expression level of PATZ1 mRNA was significantly downregu-lated in HCC tissues(P<0.05).Patients with low miR-1470 and high PATZ1 mRNA expression in HCC tis-sues had significant differences in serum alpha-fetoprotein(AFP)level,China Liver Cancer Staging System(CNLC)stage,and the presence or absence of vascular tumor thrombus(P<0.05).The expression of miR-1470 and PATZ1 mRNA was negatively correlated in HCC tissues(P<0.05).The 5-year overall survival rates of patients with low miR-1470 expression and high PATZ1 mRNA expression were significantly higher than those of patients with high miR-1470 expression and low PATZ1 mRNA expression(P<0.05).CNLC stage Ⅲ,vascular tumor thrombus,high miR-1470 expression,and low PATZ1 mRNA expression were inde-pendent risk factors for poor prognosis in HCC patients(P<0.05).miR-1470 could negatively regulate PATZ1 expression.Conclusion:miR-1470 is upregulated and PATZ1 is downregulated in HCC tissues,and the two are negatively correlated.Both can be used as biomarkers to evaluate the prognosis of HCC patients,and miR-1470 can negatively regulate PATZ1 expression.

关键词

肝癌/微小RNA-1470/POZ结构域和AT结合基序锌指蛋白1/预后

Key words

Hepatocellular carcinoma/microRNA-1470/POZ domain and AT-binding zinc fin-ger protein 1/Prognosis

引用本文复制引用

基金项目

河北省医学科学研究项目(20241159)

出版年

2024
河北医学
河北省医学会

河北医学

CSTPCD
影响因子:1.915
ISSN:1006-6233
参考文献量14
段落导航相关论文